Ameritas Advisory Services LLC purchased a new stake in Trupanion, Inc. (NASDAQ:TRUP – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,070 shares of the financial services provider’s stock, valued at approximately $389,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TRUP. GAMMA Investing LLC grew its position in Trupanion by 18.5% during the fourth quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock valued at $82,000 after purchasing an additional 267 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Trupanion by 7.3% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,861 shares of the financial services provider’s stock worth $414,000 after acquiring an additional 671 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Trupanion by 2.7% during the third quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock worth $1,189,000 after acquiring an additional 738 shares in the last quarter. Quest Partners LLC acquired a new stake in Trupanion during the third quarter valued at $37,000. Finally, Check Capital Management Inc. CA grew its stake in Trupanion by 2.7% in the third quarter. Check Capital Management Inc. CA now owns 41,460 shares of the financial services provider’s stock valued at $1,740,000 after purchasing an additional 1,100 shares in the last quarter.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on the company. Stifel Nicolaus lifted their price target on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Northland Securities boosted their target price on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Finally, Piper Sandler upgraded shares of Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price target on the stock in a report on Thursday. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $45.33.
Insider Transactions at Trupanion
In other news, CFO Fawwad Qureshi sold 9,867 shares of Trupanion stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Murray B. Low sold 2,000 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the transaction, the director now owns 131,513 shares of the company’s stock, valued at $6,926,789.71. The trade was a 1.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 28,597 shares of company stock worth $1,522,082 over the last three months. 5.50% of the stock is currently owned by insiders.
Trupanion Price Performance
Shares of Trupanion stock opened at $48.29 on Friday. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90. The firm has a fifty day simple moving average of $50.68 and a 200-day simple moving average of $45.95. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $2.04 billion, a price-to-earnings ratio of -150.91, a PEG ratio of 8.27 and a beta of 1.61.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The company had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the prior year, the company earned ($0.10) earnings per share. The business’s quarterly revenue was up 14.6% compared to the same quarter last year. On average, sell-side analysts expect that Trupanion, Inc. will post -0.2 earnings per share for the current year.
Trupanion Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- Energy and Oil Stocks Explained
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- The How and Why of Investing in Gold Stocks
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Roth IRA Calculator: Calculate Your Potential Returns
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.